{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"69","value":"15"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"dispersionType":"Full Range","groups":[{"description":"RAD001, oral, 10 mg, daily\n\nRAD001: Taken orally once a day","id":"OG000","title":"RAD001"}],"paramType":"MEDIAN","populationDescription":"13 participants were censored due to follow-up ending prior to new therapy initiation.","reportingStatus":"POSTED","timeFrame":"End of follow-up, an average of 18 months","title":"Time to Next Therapy With Single Agent RAD001 Therapy in Previously Untreated WM","type":"PRIMARY","unitOfMeasure":"Months"}